Targeted therapy

Definition

Targeted therapy refers to a type of cancer treatment that uses drugs or other substances to precisely identify and attack cancer cells, while minimizing damage to normal cells. This approach is made possible by understanding the specific genetic mutations, proteins, or tissue environments associated with different types of cancer. By focusing on these unique characteristics, targeted therapies enhance the effectiveness of treatment and reduce side effects, aligning closely with the principles of precision medicine and theranostics.

5 Must Know Facts For Your Next Test

1. Targeted therapies can specifically inhibit cancer cell growth by blocking signals necessary for tumor growth and survival.
2. These therapies often have fewer side effects than traditional chemotherapy because they selectively target cancer cells rather than all rapidly dividing cells.
3. Common examples of targeted therapies include monoclonal antibodies and small molecule inhibitors that focus on specific proteins or genes involved in cancer.
4. The effectiveness of targeted therapy often depends on identifying the presence of specific biomarkers in a patient's tumor, guiding treatment choices.
5. Targeted therapies are continuously being researched and developed, with new drugs emerging that focus on various types of cancers and their unique genetic profiles.

Review Questions

• How does targeted therapy differ from traditional cancer treatments, and what advantages does it offer?
  • Targeted therapy differs from traditional cancer treatments like chemotherapy in that it specifically targets molecular changes in cancer cells, rather than indiscriminately attacking all rapidly dividing cells. This precision allows for more effective treatment with fewer side effects. The advantages include improved patient outcomes due to better targeting of the disease and reduced harm to normal tissues, leading to a better quality of life during treatment.
• Discuss the role of biomarkers in determining the suitability of targeted therapy for individual patients.
  • Biomarkers play a crucial role in identifying which patients are most likely to benefit from targeted therapy. By analyzing genetic mutations or specific proteins present in a patient's tumor, healthcare providers can determine the most effective therapeutic options tailored to that individual's cancer profile. This biomarker-driven approach ensures that treatments are personalized, improving the chances of success and minimizing unnecessary exposure to ineffective therapies.
• Evaluate the potential future developments in targeted therapy and their implications for the field of precision medicine.
  • Future developments in targeted therapy are likely to focus on discovering new biomarkers and developing more sophisticated drugs that can target a wider array of genetic mutations across different cancers. Advances in genomics and proteomics will enable researchers to uncover previously unidentified targets, leading to more personalized treatment options. As these therapies become more refined and effective, they could significantly change the landscape of cancer treatment by enhancing patient outcomes, reducing healthcare costs associated with trial-and-error approaches, and contributing to the overall goal of precision medicine in treating various diseases.

Related terms

Precision Medicine: An approach to patient care that tailors treatment based on individual genetic, environmental, and lifestyle factors.

Biomarkers: Biological indicators, such as genes or proteins, used to identify specific disease states or responses to treatment.

Theranostics: A combined approach of therapy and diagnostics, allowing for personalized treatment strategies based on individual responses.